Two River
Two River is a merchant bank focused on the life science sector.
Business Model:
Revenue: $15.4M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Two River Information
Geographic Data
Address: 689 5th Ave
City: New York
State: NY
Zip: 10022
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
We work with experienced teams to build outstanding companies that improve health outcomes and quality of life. At Two River we tailor our approach to the needs of each opportunity, partnering with management to create, finance or operate development-stage companies in the life sciences and healthcare sectors. Two River invests in companies with strong intellectual property and proven leadership teams who have demonstrated prior success developing innovative technologies in the life sciences sector. Two River is uniquely positioned to understand and balance the needs of the finance and life science communities. Our experience building companies spans a range of industry sectors including oncology, cardiovascular disease, ophthalmology, neurological disorders and animal health. We consider each of our investments to be a partnership, often working closely with portfolio companies on product development, regulatory and corporate strategy as well as day-to-day business operations.
Contact Phone:
+12128717900
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2016 | Hubble Contacts | Seed Round | 3.7M |
| 1/2021 | IconOVir Bio | Series A | 0 |
| 10/2018 | Thirty Madison | Series A | 0 |
| 4/2018 | Allogene | Series A | 0 |
| 3/2020 | Amunix | Series A | 0 |
| 4/2020 | ByHeart | Series A | 0 |
| 7/2018 | Hubble Contacts | Series B | 0 |
| 5/2016 | Hubble Contacts | Seed Round | 3.5M |
| 5/2013 | Kite Pharma | Series A | 20M |
| 7/2021 | ByHeart | Series B | 0 |
| 3/2017 | Hubble Contacts | Series A | 16.5M |
| 8/2017 | Hubble Contacts | Series A | 10M |
| 7/2019 | Kronos Bio | Series A | 105M |
| 3/2018 | Andie | Seed Round | 2M |
| 9/2020 | Neogene Therapeutics | Series A | 110M |
| 10/2018 | Keeps | Series A | 0 |
| 6/2016 | Cell Design Labs | Equity | 34.4M |
| 7/2018 | Willow | Seed Round | 0 |
| 7/2016 | Sienna Biopharmaceuticals | Series A | 12M |
| 11/2015 | UroGen Pharma | Series A | 18M |
| 3/2011 | Kite Pharma | Series A | 15M |
| 7/2021 | ByHeart | Series B | 0 |
| 1/2021 | IconOVir Bio | Series A | 0 |
| 9/2020 | Neogene Therapeutics | Series A | 0 |
| 4/2020 | ByHeart | Series A | 0 |
| 3/2020 | Amunix | Series A | 0 |
| 7/2019 | Kronos Bio | Series A | 0 |
| 10/2018 | Keeps | Series A | 0 |
| 10/2018 | Thirty Madison | Series A | 0 |
| 7/2018 | Willow | Seed Round | 0 |
| 7/2018 | Hubble Contacts | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
